As healthcare professionals, it is crucial to understand the complexities of Parkinson's Disease (PD), a neurodegenerative disorder that has far-reaching implications on the quality of life of patients.
PD is primarily characterized by the degeneration of dopaminergic neurons in the substantia nigra, leading to a dopamine deficit in the striatum. While the exact cause remains unknown, both genetic and environmental factors are believed to play a role.
PD presents with motor symptoms such as bradykinesia, rigidity, and resting tremor. Non-motor symptoms, including cognitive impairment, mood disorders, and autonomic dysfunction, may precede motor symptoms and significantly impact a patient's life.
Diagnosis of PD is primarily clinical, based on the presence of cardinal motor symptoms and response to dopaminergic therapy. Neuroimaging techniques can provide supportive evidence but are not diagnostic.
Management of PD is symptomatic, focusing on improving quality of life. Pharmacological treatment principally involves dopamine replacement or mimicking its effects. Non-pharmacological interventions include physical therapy and deep brain stimulation.
PD is a progressive disease with no cure. However, advancements in research are promising, with ongoing studies exploring neuroprotective strategies and disease-modifying therapies.
Understanding PD's complexity is key to providing comprehensive care to patients. As healthcare professionals, we must stay updated on the latest research developments to improve patient outcomes. Continued focus on patient-centered care, encompassing not just the motor symptoms but also the non-motor manifestations of PD, will ensure a holistic approach to management.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation